This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Dipentum Capsules

UCB SA

Drug Names(s): olsalazine sodium, mesalazine, mesalamine, 5-ASA

Description: Dipentum consists of olsalazine sodium, which like sulfasalazine, is converted to 5-aminosalicylic acid (5-ASA) in the colon. It is thought that 5-ASA is the therapeutically active component of the drug. Although the exact mechanism of action of 5-ASA is unknown, it appears to inhibit the prostaglandin inflammatory cascades.


Dipentum Capsules News

Pink Sheet January Supplements


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug